WilmerHale Counsels Suono Bio in Seed Funding Led by Polaris and MIT’s The Engine
Suono Bio, a company developing a platform technology designed to enable ultra-rapid delivery of therapeutics—including proteins and nucleic acids—to the gastrointestinal tract, has announced that it has raised its seed funding round from Polaris, MIT's “The Engine” and other investors. The seed round will go toward getting the technology prepped for human trials.
The WilmerHale team counseling Suono Bio was led by Joshua Fox and included Stephanie Singer and Hilary Baker-Jennings.
Read "A company that wants to use ultrasounds to deliver drugs just raised money from MIT's new $200 million venture fund," published by Business to learn more.